TY - JOUR
AU - Schlenk, Richard
AU - Weber, Daniela
AU - Fiedler, Walter
AU - Salih, Helmut R
AU - Wulf, Gerald
AU - Salwender, Hans
AU - Schroeder, Thomas
AU - Kindler, Thomas
AU - Lübbert, Michael
AU - Wolf, Dominik
AU - Westermann, Jörg
AU - Kraemer, Doris
AU - Götze, Katharina S
AU - Horst, Heinz-August
AU - Krauter, Jürgen
AU - Girschikofsky, Michael
AU - Ringhoffer, Mark
AU - Südhoff, Thomas
AU - Held, Gerhard
AU - Derigs, Hans-Günter
AU - Schroers, Roland
AU - Greil, Richard
AU - Grießhammer, Martin
AU - Lange, Elisabeth
AU - Burchardt, Alexander
AU - Martens, Uwe
AU - Hertenstein, Bernd
AU - Marretta, Lore
AU - Heuser, Michael
AU - Thol, Felicitas
AU - Gaidzik, Verena I
AU - Herr, Wolfgang
AU - Krzykalla, Julia
AU - Benner, Axel
AU - Döhner, Konstanze
AU - Ganser, Arnold
AU - Paschka, Peter
AU - Döhner, Hartmut
TI - Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
JO - Blood
VL - 133
IS - 8
SN - 0006-4971
CY - Stanford, Calif.
PB - HighWire Press
M1 - DKFZ-2019-00681
SP - 840 - 851
PY - 2019
AB - Patients with acute myeloid leukemia (AML) and a FLT3 internal tandem duplication (ITD) have poor outcomes to current treatment. A phase 2 hypothesis-generating trial was conducted to determine whether the addition of the multitargeted kinase inhibitor midostaurin to intensive chemotherapy followed by allogeneic hematopoietic cell transplantation (alloHCT) and single-agent maintenance therapy of 12 months is feasible and favorably influences event-free survival (EFS) compared with historical controls. Patients 18 to 70 years of age with newly diagnosed AML and centrally confirmed FLT3-ITD were eligible: 284 patients were treated, including 198 younger (18-60 years) and 86 older (61-70 years) patients. Complete remission (CR) rate, including CR with incomplete hematological recovery (CRi) after induction therapy, was 76.4
LB - PUB:(DE-HGF)16
C6 - pmid:30563875
DO - DOI:10.1182/blood-2018-08-869453
UR - https://inrepo02.dkfz.de/record/143062
ER -